On the other hand, rapamycin attenuated the production of SOX protein, and it was found that combining rapamycin and temozolomide suppressed the progression of glioma in cells that expressed high levels of SOX2/SOX9 (Garros-Regulez et al. 2016). Here, SOX2 is linked to central nervous system cancer.